Literature DB >> 16245648

Antiviral and cytostatic evaluation of the novel 6-acyclic chain substituted thymine derivatives.

Svjetlana Prekupec1, Damjan Makuc, Janez Plavec, Sandra Kraljević, Marijeta Kralj, Kresimir Pavelić, Graciela Andrei, Robert Snoeck, Jan Balzarini, Erik De Clercq, Silvana Raić-Malić, Mladen Mintas.   

Abstract

A series of the novel 5-methyl pyrimidine derivatives with an acyclic side chain at the C-6 position were synthesized using lithiation of a 2,4-dimethoxy-5,6-dimethyl pyrimidine and subsequent nucleophilic addition or substitution reactions of the organolithium intermediate thus obtained with acetaldehyde, epichlorhydrine, fluorinated ketones and fluorinated ester. The novel compounds were evaluated for their cytostatic and antiviral activities. Among all the compounds evaluated, two fluorinated acyclic pyrimidine derivatives showed the highest cytostatic activities. The compound containing a 2-hydroxy-3,3,3-trifluoro-1-propenyl side chain exhibited a pronounced effect against breast carcinoma (MCF-7, IC50=8.38 micorg/ml), while the compound with a 2-fluoromethyl-2-acetoxypropyl chain exhibited moderate effect against cervical carcinoma (HeLa, IC50=19.73 microg/ml).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16245648     DOI: 10.1177/095632020501600505

Source DB:  PubMed          Journal:  Antivir Chem Chemother        ISSN: 0956-3202


  2 in total

1.  Methoxymethyl (MOM) group nitrogen protection of pyrimidines bearing C-6 acyclic side-chains.

Authors:  Tatjana Gazivoda Kraljević; Martina Petrović; Svjetlana Krištafor; Damjan Makuc; Janez Plavec; Tobias L Ross; Simon M Ametamey; Silvana Raić-Malić
Journal:  Molecules       Date:  2011-06-20       Impact factor: 4.411

2.  Synthesis, structural studies and antitumoral evaluation of C-6 alkyl and alkenyl side chain pyrimidine derivatives.

Authors:  Svjetlana Kristafor; Tatjana Gazivoda Kraljević; Damjan Makuc; Janez Plavec; Lidija Suman; Marijeta Kralj; Silvana Raić-Malić
Journal:  Molecules       Date:  2009-11-27       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.